Stomach Cancer Trial, Recruiting NCT06202105 Sponsor: University Medical Center Ho Chi Minh City (UMC) Condition: Stomach Cancer
Back to Stomach Cancer

Stomach Cancer Trial, Recruiting

NCT06202105
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with stomach cancer (specifically a type called adenocarcinoma), confirmed by a camera procedure looking inside your stomach (endoscopy)
  • You are between 18 and 80 years old
  • Your cancer requires a full removal of the stomach as part of your treatment
  • Your cancer is at a specific stage based on CT scan results (stages cT2 to cT4a, with no distant spread to other parts of the body)
  • Your overall health has been assessed as suitable for surgery (a standard health scoring system rates you at 3 or below)
  • You are willing and able to give informed consent to take part in the trial

Who may not be able to join:

  • You currently have another type of cancer, or you were previously treated for a different cancer before your stomach cancer diagnosis
  • Your cancer has spread to large clusters of lymph nodes or to lymph nodes near the main artery in your abdomen (confirm with trial site)
  • Your treatment would require removal of part of the food pipe (esophagus) as well as the stomach, because the cancer has grown into that area
  • You are pregnant

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 5 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University Medical Center Ho Chi Minh City (UMC)
Registry
ClinicalTrials.gov
Start date
2 August 2024
Est. completion
2 August 2032

Where this trial is recruiting

🇻🇳 Vietnam

Primary endpoints

3 year overall survival by Kaplan Mayer; 3 year relapse-free survival by Kaplan Mayer

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov